PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Your new post is loading...
Your new post is loading...
Krishan Maggon 's curator insight,
August 23, 2014 9:08 PM
Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated diseaseJ. Charles Jennette& Ronald J. FalkAffiliationsContributionsCorresponding authorNature Reviews Rheumatology 10, 463–473 (2014) doi:10.1038/nrrheum.2014.103Published online 08 July 2014
Société Francaise d'Immunologie's comment,
August 22, 2014 5:38 AM
a novel anti-CAF-1 autoantibody is frequently found in patients with SLE and is a useful biomarker for diagnosis, especially in cases with CNS involvement.
|
Société Francaise d'Immunologie's comment,
July 16, 2014 8:36 AM
What we have done is use state-of-the-art technology to come up with a cheap test that uses just a drop of blood and tells people in hours if they have autoantibodies or not.
We really think this technology can be pushed to the bedside very quickly to diagnose between type 1 and type 2. These autoantibodies are the final say in type 1 diabetes? There are basically three autoantibodies that we can measure, simultaneously, and their risk is cumulative. If you have one present, your risk is increased 10 to 20 percent; if all three are present, you have greater than 90 percent risk of developing diabetes in the future.
Société Francaise d'Immunologie's comment,
July 16, 2014 8:37 AM
it is not so difficult with IF technology, and cheaper in europe?
|